Ligand to Hold Fourth Quarter Results Conference Call on February 12

Show Health and Fitness Publications

Thu, February 5, 2009

[ Thu, Feb 05th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation Announces Fourth Quarter and Full Year 2008 Results

[ Thu, Feb 05th 2009 ] - Market Wire

King Pharmaceuticals Offers New Dosage Strengths .. re Treatment Options for People with Chronic Pain

[ Thu, Feb 05th 2009 ] - Market Wire

GeneThera: GeneThera Offers Discounted Johne's Di .. ted by Government's Call to Eliminate 400,000 Hea

[ Thu, Feb 05th 2009 ] - Market Wire

Applied Biosystems Awards Genomic Research Grant to St. Jude Children?s Research Hospital

[ Thu, Feb 05th 2009 ] - Market Wire

StemCells, Inc. to Present at the 11th Annual BIO CEO & Investor Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Dr. Reddy?s Announces Five ANDA Approvals and Generic Product Launches in the US Market

[ Thu, Feb 05th 2009 ] - Market Wire

GTx, Inc. Announces Fourth Quarter and Year End 2008 Corporate Results Conference Call and Webcast

[ Thu, Feb 05th 2009 ] - Market Wire

BioDelivery Sciences Announces Initial Results of Phase 1 Clinical Study of Bioral Amphotericin B

[ Thu, Feb 05th 2009 ] - Market Wire

Cytori Patent Allowance Expands Celution® System .. n for Adipose Stem & Regenerative Cell Processing

[ Thu, Feb 05th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. he 2009 UBS Global Healthcare Services Conference

[ Thu, Feb 05th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Myriad G .. , School Specialty, Exxon, Chevron and Transocean

[ Thu, Feb 05th 2009 ] - Market Wire

Illumina Presents Development Roadmap for Scaling its Genome Analyzer

[ Thu, Feb 05th 2009 ] - Market Wire

Exelixis Announces February 10 Webcast of Present .. at the 11th Annual BIO CEO & Investor Conference

Wed, February 4, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Sun Healthcare Group, Inc.: Sun Healthcare Group, .. ; Schedules Conference Call to Announce 2008 Earn

[ Wed, Feb 04th 2009 ] - Market Wire

NPS Pharmaceuticals to Present at BIO CEO & Investor Conference

[ Wed, Feb 04th 2009 ] - Market Wire

Toxin Alert Inc.: Andersen Resigns From Toxin Alert Board

[ Wed, Feb 04th 2009 ] - Market Wire

Inhibitex to Present at the 11th Annual BIO CEO & Investor Conference

[ Wed, Feb 04th 2009 ] - Market Wire

Urigen Pharmaceuticals: Urigen Announces Recent Insider Purchases Total Over 500,000 Shares

[ Wed, Feb 04th 2009 ] - Market Wire

Theravance, Inc.: GSK and Theravance announce pos .. nce-daily fluticasone furoate in the treatment of

[ Wed, Feb 04th 2009 ] - Market Wire

Helicos Announces Improved Performance of Its Hel .. pe" Single Molecule Sequencer and tSMS" Chemistry

[ Wed, Feb 04th 2009 ] - Market Wire

Biofield Corp. Expands Arsenal Of Non-Invasive Diagnostic Devices

[ Wed, Feb 04th 2009 ] - Market Wire

Bio-Imaging Technologies to Release Fourth Quarte .. Results and Host Conference Call on February 11,

[ Wed, Feb 04th 2009 ] - Market Wire

Oragenics, Inc., Announces Agreement with Garden of Life, Inc., for Use of ProBiora3

[ Wed, Feb 04th 2009 ] - Market Wire

Progenics Appoints Peter J. Crowley as Independent Board Member

[ Wed, Feb 04th 2009 ] - Market Wire

UnitedHealth Group Makes It Simpler for Physician .. nister Health Care with Updated Customer ID Cards

[ Wed, Feb 04th 2009 ] - Market Wire

EXACT Sciences Announces Issuance of Key Patent C .. ing Vimentin Gene for Colorectal Cancer Screening

[ Wed, Feb 04th 2009 ] - Market Wire

Applied Biosystems Delivers Integrated, Application-Focused Solutions on New SOLiD 3 System

[ Wed, Feb 04th 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. arter and Full Year 2008 Results and Conduct Conf

[ Wed, Feb 04th 2009 ] - Market Wire

MEDNAX, Inc. Acquires Neonatal Practice

[ Wed, Feb 04th 2009 ] - Market Wire

Compugen Ltd. to Review Fourth Quarter and Year-E .. Financial Results on Wednesday, February 11, 2009

[ Wed, Feb 04th 2009 ] - Market Wire

Sequenom to Hold Fourth Quarter and Full Year 200 .. Financial Results Conference Call on February 11

[ Wed, Feb 04th 2009 ] - Market Wire

Xenomics, Inc. Restructures and Extends Maturity of Convertible Debentures

Tue, February 3, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Community Health Systems to Participate in the 2009 UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

NexMed Announces Sale of U.S. Rights for Topical Erectile Dysfunction Treatment

[ Tue, Feb 03rd 2009 ] - Market Wire

ACADIA Pharmaceuticals to Present at the BIO CEO & Investor Conference on February 10, 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

BioReference Laboratories, Inc to Speak at The UBS Global Healthcare Services Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Response Genetics Signs Agreement With Roche Diagnostics to Support Cancer Test Development

[ Tue, Feb 03rd 2009 ] - Market Wire

Affymax to Present at BIO CEO and Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

King Pharmaceuticals Announces Corporate Restructuring to Reduce Operating Expenses

[ Tue, Feb 03rd 2009 ] - Market Wire

PerkinElmer Expands LED Portfolio with Acquisition of Opto Technology, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Myriad Genetics: Myriad Genetics, Inc. Reports Results for Second Quarter of Fiscal 2009

[ Tue, Feb 03rd 2009 ] - Market Wire

Sequenom Announces Findings on Methylation Markers and RNA-SNP Markers as Presented at SMFM

[ Tue, Feb 03rd 2009 ] - Market Wire

Amarin to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Reflect Scientific: $400,000 Order for Newly Rele .. 7000 System Received by Reflect Scientific, Inc.

[ Tue, Feb 03rd 2009 ] - Market Wire

Acorda Therapeutics to Present at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Amedisys Acquires Two Home Health Agencies in Arizona

[ Tue, Feb 03rd 2009 ] - Market Wire

GTx Announces Webcast of Corporate Presentation at the 11th Annual BIO CEO & Investor Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

CeragenixAchieves 120 Daysof Antimicrobial Efficacy on Treated Silicone Medical Device.

[ Tue, Feb 03rd 2009 ] - Market Wire

Inspire Announces Webcast of Presentation at BIO CEO Conference

[ Tue, Feb 03rd 2009 ] - Market Wire

Compugen Announces Discovery of Biomarker Candida .. ian Cancer and Signing of Collaboration Agreement

[ Tue, Feb 03rd 2009 ] - Market Wire

Endologix to Hold 2008 Fourth Quarter and Full Ye .. Financial Results Conference Call on February 19

Mon, February 2, 2009

[ Mon, Feb 02nd 2009 ] - Market Wire

Kindred Healthcare to Present at the UBS Global Healthcare Services Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

LHC Group and Ochsner Health System Complete Home Health Joint Venture

[ Mon, Feb 02nd 2009 ] - Market Wire

Corcept Therapeutics: CORLUX(R) Mitigates Weight .. al(R), Expands on Proof of Concept Established in

[ Mon, Feb 02nd 2009 ] - Market Wire

Medtronic Completes Enrollment in Global Head-to-Head Stent-Safety Study

[ Mon, Feb 02nd 2009 ] - Market Wire

Wright Medical Group, Inc. to Host Fourth Quarter 2008 Earnings Conference Call

[ Mon, Feb 02nd 2009 ] - Market Wire

Allos Therapeutics to Present at the 2009 BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Aetna Awarded $600,000 to Non-Profits in Maryland, Virginia and the District of Columbia

[ Mon, Feb 02nd 2009 ] - Market Wire

ZIOPHARM Oncology to Present at the 11th Annual BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Synta Completes Enrollment of the Phase 3 SYMMETR .. ial of Elesclomol in Stage IV Metastatic Melanoma

[ Mon, Feb 02nd 2009 ] - Market Wire

Community Health Systems, Inc. Announces the Acquisition of Siloam Springs, Arkansas Hospital

[ Mon, Feb 02nd 2009 ] - Market Wire

Auxilium Pharmaceuticals, Inc.: Auxilium Pharmace .. llment in Phase IIb Clinical Trial of XIAFLEX(TM)

[ Mon, Feb 02nd 2009 ] - Market Wire

Ceragenix and Hyphens Enter Into Distribution and Supply Agreement for EpiCeram®

[ Mon, Feb 02nd 2009 ] - Market Wire

Idera Pharmaceuticals Announces Achievement of Cl .. ollaboration with Merck KGaA for Cancer Treatment

[ Mon, Feb 02nd 2009 ] - Market Wire

Acorda Therapeutics Submits New Drug Application .. ment of Walking Ability in People with Multiple S

[ Mon, Feb 02nd 2009 ] - Market Wire

LifePoint Hospitals Acquires Rockdale Medical Center

[ Mon, Feb 02nd 2009 ] - Market Wire

SciClone Pharmaceuticals, Inc.: SciClone Pharmace .. icals to Present at BIO CEO & Investor Conference

[ Mon, Feb 02nd 2009 ] - Market Wire

Syneron Medical Ltd.: Syneron Medical Announces M .. Strengthening of Syneron's Leadership Position in

[ Mon, Feb 02nd 2009 ] - Market Wire

ZymoGenetics to Host Conference Call and Webcast .. , 2009 to Discuss 2008 Year-End Financial Results

Sun, February 1, 2009

[ Sun, Feb 01st 2009 ] - Market Wire

FORTIS: Fortis holding announcement

Sat, January 31, 2009

[ Sat, Jan 31st 2009 ] - Market Wire

FORTIS: Fortis holding publishes addendum to shareholder circular

[ Sat, Jan 31st 2009 ] - Market Wire

Resumen: REVLIMID® recibe recomendacin prelimina .. nal para la Salud y la Excelencia Clnica (NICE en

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® riceve indicazione preliminare positiv .. ealth and Clinical Excellence (NICE) per l'uso ne

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® erhlt die vorlufige Empfehlung des bri .. r Health and Clinical Excellence (NICE) zur Anwen

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® reoit un avis pr©alable favorable de .. et de l'excellence clinique (INEC) pour tre util

[ Sat, Jan 31st 2009 ] - Market Wire

REVLIMID® ontvangt positieve aanbeveling van het .. and Clinical Excellence (NICE) voor gebruik in d

Fri, January 30, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Biodel to Report First Quarter Fiscal Year 2009 R .. sults of Bioequivalence Study on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

Abiomed Third Fiscal Quarter 2009 Earnings and Conference Call Notification

[ Fri, Jan 30th 2009 ] - Market Wire

Teva Announces Approval of Generic Risperdal® Oral Solution

[ Fri, Jan 30th 2009 ] - Market Wire

Daxor Corp.: Daxor Announces Tahlequah City Hospi .. lequah, OK Acquires BVA-100 Blood Volume Analyzer

[ Fri, Jan 30th 2009 ] - Market Wire

First Patient Treated in Adipose Stem & Regenerative Cell Study for Stress Urinary Incontinence

[ Fri, Jan 30th 2009 ] - Market Wire

DexCom Announces Pricing of Public Offering of Common Stock

[ Fri, Jan 30th 2009 ] - Market Wire

Health Management Associates, Inc. to Present at .. lobal High Yield and Leveraged Finance Conference

[ Fri, Jan 30th 2009 ] - Market Wire

GeneThera: Dr. Antonio Milici of GeneThera Nomina .. for National Advisory Committee on Meat & Poultry

[ Fri, Jan 30th 2009 ] - Market Wire

CONMED Corporation: CONMED Corporation to Announc .. uarter 2008 Financial Results on February 5, 2009

[ Fri, Jan 30th 2009 ] - Market Wire

King Pharmaceuticals Announces Positive Results f .. ety and Efficacy Study of EMBEDA" Extended Releas

[ Fri, Jan 30th 2009 ] - Market Wire

Progen-Avexa Merger Update

[ Fri, Jan 30th 2009 ] - Market Wire

St. Jude Medical Announces 2009 Annual Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

SonoSite Introduces Powerful New Turbo Technology for S Series"

[ Fri, Jan 30th 2009 ] - Market Wire

GTx Congratulates Dr. Duane D. Miller on His Indu .. Chemical Society Medicinal Chemistry Hall of Fame

[ Fri, Jan 30th 2009 ] - Market Wire

Hollis-Eden Pharmaceuticals to Present at 2009 BIO CEO and Investor Conference

[ Fri, Jan 30th 2009 ] - Market Wire

Forbes Names Illumina America?s Fastest-Growing Technology Company for Second Time

[ Fri, Jan 30th 2009 ] - Market Wire

REVLIMID® Receives Preliminary Positive Recommen .. for Health and Clinical Excellence (NICE) for Us

[ Fri, Jan 30th 2009 ] - Market Wire

Santarus Submits New Drug Application for ZEGERID Tablet Product

Thu, January 29, 2009

[ Thu, Jan 29th 2009 ] - Market Wire

EXACT Sciences Regains NASDAQ Compliance

[ Thu, Jan 29th 2009 ] - Market Wire

CompCare Acquires Core Corporate Consulting Group, Inc.

[ Thu, Jan 29th 2009 ] - Market Wire

Watson Pharmaceuticals: Watson to Host Fourth Qua .. ll Year 2008 Earnings Conference Call and Webcast

[ Thu, Jan 29th 2009 ] - Market Wire

Seattle Genetics to Host Conference Call and Webc .. ter and Year 2008 Financial Results on February 5

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $125,000 to North Carolina Non-Profits

[ Thu, Jan 29th 2009 ] - Market Wire

Aetna Awarded $857,500 to Non-Profits in Florida

[ Thu, Jan 29th 2009 ] - Market Wire

Bio-Imaging Technologies to Present at the UBS Gl .. erence on February 9, 2009 at the Waldorf Astoria

[ Thu, Jan 29th 2009 ] - Market Wire

Eurand N.V.: FDA Accepts Eurand's Response to Approvable Letter for EUR-1008 as Complete

[ Thu, Jan 29th 2009 ] - Market Wire

Synta Pharmaceuticals to Present at the BIO CEO & Investor Conference 2009

[ Thu, Jan 29th 2009 ] - Market Wire

Humana and Wisconsin Health Information Exchange Announce Collaborative Business Program

[ Thu, Jan 29th 2009 ] - Market Wire

Data from Columbia Laboratories? Study for the Pr .. be Presented at the Society for Maternal-Fetal Me

[ Thu, Jan 29th 2009 ] - Market Wire

ARIAD to Webcast Conference Call on Fourth Quarter and Year-End 2008 Financial Results

[ Thu, Jan 29th 2009 ] - Market Wire

University of Texas at Austin Acquires SOLiD System to Advance Genomic Research

[ Thu, Jan 29th 2009 ] - Market Wire

Alexion?s Soliris(R) (eculizumab) Receives Marketing Approval in Canada for All Patients with PNH

[ Thu, Jan 29th 2009 ] - Market Wire

Spectranetics Announces Executive Appointments to Further Enhance Compliance Programs

[ Thu, Jan 29th 2009 ] - Market Wire

Transcend Reports 18% Revenue Growth, 28% Increas .. in Pre-Tax Income and Earnings Per Share of $.17

[ Thu, Jan 29th 2009 ] - Market Wire

POZEN Informed by FDA That Endoscopic Gastric Ulc .. ce Continues to Be an Acceptable Primary Endpoint

[ Thu, Jan 29th 2009 ] - Market Wire

Micrus Endovascular to Hold Fiscal 2009 Third Quarter Conference Call on February 5

Wed, January 28, 2009

[ Wed, Jan 28th 2009 ] - Market Wire

Enzon Nominates Two New Candidates for Its Board of Directors

[ Wed, Jan 28th 2009 ] - Market Wire

Aetna Announces 2009 Annual Meeting Details

[ Wed, Jan 28th 2009 ] - Market Wire

CombinatoRx Publishes Data on Selective Amplification of Synergistic Combination Drug Candidate

[ Wed, Jan 28th 2009 ] - Market Wire

Sepracor Announces Strategic Corporate Restructur .. ction Plan in Addition to 2009 Financial Guidance

[ Wed, Jan 28th 2009 ] - Market Wire

Positron Corporation?s Joint Venture Submits FDA 510(k) for its Attrius" PET Scanner

[ Wed, Jan 28th 2009 ] - Market Wire

Hansen Medical, Inc.: Hansen Medical Announces 2008 Fourth Quarter Conference Call

[ Wed, Jan 28th 2009 ] - Market Wire

Vitro Receives Notice of Allowance for Adult Stem .. rom the United States Patent and Trademark Office

[ Wed, Jan 28th 2009 ] - Market Wire

Resumen: Gilead esboza las prioridades de I+D para 2009

[ Wed, Jan 28th 2009 ] - Market Wire

Samenvatting: Gilead zet prioriteiten O&O uiteen voor 2009

[ Wed, Jan 28th 2009 ] - Market Wire

Gilead gibt Schwerpunkte fr Forschung und Entwicklung 2009 bekannt

[ Wed, Jan 28th 2009 ] - Market Wire

Synovis Life Technologies to Webcast Fiscal First .. r Earnings Conference Call Wednesday, February 25

[ Wed, Jan 28th 2009 ] - Market Wire

VIVUS Announces Senior Management Promotions

[ Wed, Jan 28th 2009 ] - Market Wire

Geron Announces John Walker Resigns as Director

[ Wed, Jan 28th 2009 ] - Market Wire

Sequenom Terminates Exchange Offer to Acquire EXACT Sciences

[ Wed, Jan 28th 2009 ] - Market Wire

Medtronic Expands CURE-AF Clinical Program into Europe and Canada

[ Wed, Jan 28th 2009 ] - Market Wire

ImmunoGen, Inc. Announces Webcast of its Investment Community Meeting on February 27, 2009

[ Wed, Jan 28th 2009 ] - Market Wire

U.S. FDA Approves OraQuick ADVANCE® 12-Month Shelf Life Dating

[ Wed, Jan 28th 2009 ] - Market Wire

ZymoGenetics Secures Worldwide Rights to IL-21

Tue, January 27, 2009

[ Tue, Jan 27th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Inc. Prov .. ication on Engagement of Investor Relations Group

[ Tue, Jan 27th 2009 ] - Market Wire

UnitedHealth Group/PacifiCare Awards More Than $5 .. Grants to Help Improve Health Care in California

[ Tue, Jan 27th 2009 ] - Market Wire

Cavit Sciences, Inc.: Cavit Sciences Announces Update to Shareholders

[ Tue, Jan 27th 2009 ] - Market Wire

UnitedHealth Group?s Evercare Business Awarded for Innovation in Coordinated Care

[ Tue, Jan 27th 2009 ] - Market Wire

Allana Resources Inc.: Allana Resources Inc. Engages Investor Relations Group

[ Tue, Jan 27th 2009 ] - Market Wire

Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash

[ Tue, Jan 27th 2009 ] - Market Wire

Oculus Innovative Sciences Announces $3 Million I .. tner to Fund Oculus to Profitability in 12 Months

[ Tue, Jan 27th 2009 ] - Market Wire

DOR BioPharma, Inc.: DOR BioPharma Announces Appo .. pher J. Schaber, PhD, to BioNJ Board of Directors

[ Tue, Jan 27th 2009 ] - Market Wire

Alnylam Promotes Akshay Vaishnaw to Senior Vice President, Clinical Research

[ Tue, Jan 27th 2009 ] - Market Wire

St. Jude Medical Reports Fourth Quarter and Full-Year 2008 Results

[ Tue, Jan 27th 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific Adds Midwest Sales Representative

[ Tue, Jan 27th 2009 ] - Market Wire

Sequenom Commences Exchange Offer to Acquire EXACT Sciences

[ Tue, Jan 27th 2009 ] - Market Wire

PhotoMedex Announces Effectiveness of 1-for-7 Reverse Stock Split

[ Tue, Jan 27th 2009 ] - Market Wire

Amedisys Signs Purchase Agreement for Three Home Health Agencies and One Hospice Agency

[ Tue, Jan 27th 2009 ] - Market Wire

Inspire Initiates Phase 3 Prolacria" Dry Eye Trial under Special Protocol Assessment Agreement

[ Tue, Jan 27th 2009 ] - Market Wire

Illumina Launches Suite of Next-Generation Sequencing Kits

[ Tue, Jan 27th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: Onyx Pha .. wfield Exploration, D.R. Horton, KB Home and MGIC

[ Tue, Jan 27th 2009 ] - Market Wire

SCOR: SCOR sets up Zurich Hub

Mon, January 26, 2009

[ Mon, Jan 26th 2009 ] - Market Wire

Oculus Innovative Sciences Reduces Additional Cas .. ion as Company Targets Breakeven Within 12 Months

[ Mon, Jan 26th 2009 ] - jason scholder

First Stem Cell Study For Spinal Injury Approved. New Hope For Back Pain Sufferers Worldwide.

[ Mon, Jan 26th 2009 ] - Market Wire

Theravance, Inc.: Theravance Submits U.S. NDA for .. for the Treatment of Hospital-Acquired Pneumonia

[ Mon, Jan 26th 2009 ] - Market Wire

HealthSpring to Webcast Its Investor Day on February 27, 2009

[ Mon, Jan 26th 2009 ] - Market Wire

PhotoMedex Announces Results of Stockholders? Meeting

[ Mon, Jan 26th 2009 ] - Market Wire

DelSite, Inc.: DelSite, Inc. Discontinues Manufac .. DA Approval to Initiate Phase I Clinical Study fo

[ Mon, Jan 26th 2009 ] - Market Wire

Mannatech Launches Economic Stimulus Plan for Business Builders

[ Mon, Jan 26th 2009 ] - Market Wire

Seattle Genetics Receives Orphan Drug Designations for SGN-35 in the United States and Europe

[ Mon, Jan 26th 2009 ] - Market Wire

Altus Pharmaceuticals Realigns Product Developmen .. on Long-Acting Growth Hormone Candidate ALTU-238

[ Mon, Jan 26th 2009 ] - Market Wire

DOR BioPharma, Inc.: DOR BioPharma Announces Form .. Acute Radiation Enteritis Medical Advisory Board

[ Mon, Jan 26th 2009 ] - Market Wire

Endurance Athletes Get High-Quality Results with Low-Cal Accelerade Hydro and Endurox Restore

[ Mon, Jan 26th 2009 ] - Market Wire

St. Jude Medical Announces European CE Mark Appro .. Brain Stimulation Systems for Parkinson?s Disease

[ Mon, Jan 26th 2009 ] - Market Wire

Collaboration Between RXi Pharmaceuticals and the .. Medical School Receives a Massachusetts Life Scie

[ Mon, Jan 26th 2009 ] - Market Wire

MEDNAX 2008 Fourth Quarter Conference Call/Webcast Scheduled for February 5, 2009

[ Mon, Jan 26th 2009 ] - Market Wire

Sequenom Names Allan T. Bombard, M.D., Chief Medical Officer

[ Mon, Jan 26th 2009 ] - Market Wire

MEDIA ADVISORY: Pfizer and Wyeth to Host Live Press Conference in New York

[ Mon, Jan 26th 2009 ] - Market Wire

Pfizer to Acquire Wyeth, Creating the World's Premier Biopharmaceutical Company

[ Mon, Jan 26th 2009 ] - Market Wire

WellCare Files 2007 Annual Report on Form 10-K

[ Mon, Jan 26th 2009 ] - Market Wire

Zacks Bull & Bear of the Day Highlights: WellPoin .. tech, Green Mountain Coffee, Peet's and Starbucks

Sun, January 25, 2009

[ Sun, Jan 25th 2009 ] - Market Wire

Crucell N.V.: Discussions on a Combination of Crucell and Wyeth Discontinued

[ Sun, Jan 25th 2009 ] - Marc Woodard

Heal Back Pain Without Surgery - Embryonic Stem Cell Update!

Fri, January 23, 2009

[ Fri, Jan 23rd 2009 ] - Market Wire

Alcon Placed for the 11th Consecutive Year on FOR .. agazine?s List of 100 Best Companies to Work For?

[ Fri, Jan 23rd 2009 ] - Market Wire

Advanced Viral Research Corp.: Advanced Viral Ann .. f Operations Due to Inability to Secure Financing

[ Fri, Jan 23rd 2009 ] - Market Wire

Urologix to Host Its Fiscal 2009 Second Quarter Conference Call

[ Fri, Jan 23rd 2009 ] - Market Wire

NeoPharm, Inc. Announces Voluntary Delisting from NASDAQ and Deregistration of Common Stock

[ Fri, Jan 23rd 2009 ] - Market Wire

Sepracor Inc. Sets Conference Call and Webcast fo .. urth Quarter and Full-Year 2008 Operating Results

[ Fri, Jan 23rd 2009 ] - Market Wire

ImClone Systems and Bristol-Myers Squibb Update t .. ung Cancer Supplemental Biologics Application Sub

[ Fri, Jan 23rd 2009 ] - Market Wire

CLX Medical, Inc.: CLX Medical, Inc. Issues CEO C .. ith Ownership and Planned Distribution of FDA Cle

[ Fri, Jan 23rd 2009 ] - Market Wire

International Stem Cell Receives Second $1M Tranche Under $5 Million Financing

[ Fri, Jan 23rd 2009 ] - Market Wire

Alnylam Receives Clearance from FDA to Initiate P .. y with ALN-VSP for the Treatment of Liver Cancers

[ Fri, Jan 23rd 2009 ] - Market Wire

Hollis-Eden Researchers Present New Findings on M .. ancer Drug Candidate APOPTONE" (HE3235) at Americ

[ Fri, Jan 23rd 2009 ] - Market Wire

GTx Announces Conference Call to Discuss EMEA Label Changes to Fareston®

[ Fri, Jan 23rd 2009 ] - Market Wire

Centene Corporation?s Georgia Subsidiary Receives Prestigious NCQA Accreditation

[ Fri, Jan 23rd 2009 ] - Market Wire

Zacks Bull and Bear of the Day Highlights: Abbott Labs, Hubbell, Wipro, Citigroup and Infosys

Thu, January 22, 2009

[ Thu, Jan 22nd 2009 ] - Market Wire

Life Technologies Sets 4th Quarter and Full Year .. ings Release Date for Thursday, February 12, 2009

[ Thu, Jan 22nd 2009 ] - Market Wire

Span-America Reports Results for First Quarter of Fiscal 2009

[ Thu, Jan 22nd 2009 ] - Market Wire

Cubist Pharmaceuticals Reports GAAP Diluted Net I .. ourth Quarter 2008 and GAAP Diluted Net Income of

[ Thu, Jan 22nd 2009 ] - Market Wire

OPKO Health Initiates Clinical Trial of the Aquashunt" to Treat Glaucoma

[ Thu, Jan 22nd 2009 ] - Market Wire

Proton Laboratories Inc.: Transparency - Sales - .. ton Laboratories Building on Years of Development

[ Thu, Jan 22nd 2009 ] - Market Wire

Bard to Host Earnings Conference Call on January 29, 2009

[ Thu, Jan 22nd 2009 ] - Market Wire

Midland Exploration Inc.: New Drill Program on Midland Exporation's Maritime Cadillac Property

[ Thu, Jan 22nd 2009 ] - Market Wire

LifeVantage Names Network Marketing Expert Randal Wojta as Master Distributor for the Company

[ Thu, Jan 22nd 2009 ] - Market Wire

Simon Stevens Appointed Executive Vice President .. terprise-Wide Health Care Reform Engagement; Will

[ Thu, Jan 22nd 2009 ] - Market Wire

RXi Pharmaceuticals Appoints Rudolph Nisi, M.D. to Board of Directors

[ Thu, Jan 22nd 2009 ] - Market Wire

Antares Pharma Receives Milestone Payment from Teva for Pen Injector Device Filing

[ Thu, Jan 22nd 2009 ] - Market Wire

ZOLL Receives Clearance to Market New R Series BLS and R Series Plus Defibrillators

[ Thu, Jan 22nd 2009 ] - Market Wire

Ottawa Paramedic Service Awards ZOLL a Third Contract as Preferred Vendor for Defibrillators

[ Thu, Jan 22nd 2009 ] - Market Wire

OR-Live, Inc.: REMINDER: Surgical Tutorial on da Vinci(R) Anterior Pelvic Exenteration

[ Thu, Jan 22nd 2009 ] - Market Wire

Reflect Scientific: Reflect Scientific, Inc. Rece .. Design Contract for Controlled Environment System

[ Thu, Jan 22nd 2009 ] - Market Wire

Tenet Announces Preliminary Results for Fourth Quarter and Full Year 2008

[ Thu, Jan 22nd 2009 ] - Market Wire

Tenet Announces Exchange Offer for up to $1.6 Bil .. egate Principal Amount of Notes Due 2011 and 2012

[ Thu, Jan 22nd 2009 ] - Market Wire

ImmunoGen, Inc. Announces Conference Call to Disc .. Second Quarter Fiscal Year 2009 Financial Results

Ligand to Hold Fourth Quarter Results Conference Call on February 12

_{//health-fitness.news-articles.net/content/2009/ .. rter-results-conference-call-on-february-12.html}
^{Published in Health and Fitness on Thursday, January 29th 2009 at 18:15 GMT, Last Modified on 2009-01-29 18:16:14 by Market Wire}

SAN DIEGO--([ BUSINESS WIRE ])--Ligand Pharmaceuticals Incorporated (NASDAQ:LGND) announced today that it plans to report fourth quarter 2008 financial results on Thursday, February 12, 2009, following the close of market. Ligand's President and CEO, John L. Higgins, Vice President of Finance and CFO, John Sharp and Vice President of Discovery Research,

Dr. Martin Meglasson will host the conference call.

What:		Ligand Pharmaceuticals conference call to discuss financial results and provide general business updates.

When:		Thursday, February 12, 2009

Time:		1:30 p.m. Pacific time (4:30 p.m. Eastern time)

Webcast:		Conference call and replay accessible at [ www.ligand.com ].

Conference Call:		(877) 356-5578, ID # 82608477 (U.S.)

Replay:		(800) 642-1687, ID # 82608477 (U.S.)
		Replay of conference call will be available from February 12, 2009 to March 12, 2009.

About Ligand Pharmaceuticals

Ligand discovers and develops new drugs that address critical unmet medical needs of patients with muscle wasting, frailty, hormone-related diseases, osteoporosis, inflammatory diseases and anemia. Ligand's proprietary drug discovery and development programs are based on its leadership position in gene transcription technology.

Publication Contributing Sources

Market Wire is a Trusted Source

Market Wire

Similar Health and Fitness Publications

[ Wed, Jan 21st 2009 ] - Market Wire

Ligand Announces Board of Directors Changes

[ Wed, Jan 21st 2009 ] - Market Wire

AVI BioPharma, Inc.: AVI BioPharma Announces Succ .. 4658 for Treatment of Duchenne Muscular Dystrophy

[ Tue, Jan 20th 2009 ] - Market Wire

AspenBio Pharma, Inc.: AspenBio Pharma Reports Preliminary Results of AppyScore(TM) Clinical Study

[ Tue, Jan 20th 2009 ] - Market Wire

Illumina to Announce Fourth Quarter and Fiscal Ye .. 08 Financial Results on Tuesday, February 3, 2009

[ Tue, Jan 13th 2009 ] - Market Wire

Incyte to Announce 2009 Objectives at JPMorgan He .. onference; JAK Inhibitor Program Highest Priority

[ Mon, Jan 12th 2009 ] - Market Wire

SonoSite Projects Record Revenue and Operating Income for 2008

[ Mon, Jan 12th 2009 ] - Market Wire

Cubist Pharmaceuticals Announces Full Year 2008 Total Net Revenues of $433.6 Million

[ Wed, Jan 07th 2009 ] - Market Wire

Clinical Data, Inc. Reports Advances in Two Late-Stage Therapeutic Programs

[ Tue, Dec 23rd 2008 ] - Market Wire

Ligand Completes Pharmacopeia Acquisition

[ Thu, Dec 18th 2008 ] - Market Wire

Ligand Enters into Exclusive License Agreement wi .. Rights to LGD-4665 and other Ligand Thrombopoiet

[ Mon, Dec 08th 2008 ] - Market Wire

Ligand Presents Positive LGD-4665 Clinical Trial .. theAmerican Society of Hematology Annual Meeting

[ Wed, Nov 19th 2008 ] - Market Wire

GenVec Announces Interim Survival Data in Pivotal .. TNFerade"¢in Locally Advanced Pancreatic Cancer